|
6/18/2013 8:25:32 AM
|
|
|
6/17/2013 8:51:06 AM
|
HeartWare Gets Conditional Approval From FDA To Enroll Supplemental Patient Cohort In Destination Therapy Trial
|
|
6/12/2013 10:00:21 AM
|
|
|
6/12/2013 8:07:10 AM
|
HeartWare International Plans To Delist From Australian Securities Exchange
|
|
5/20/2013 10:00:30 AM
|
|
|
5/13/2013 12:38:48 PM
|
Barclays Capital Reiterates HeartWare International Inc. (HTWR) At Overweight With $100 Price Target
|
|
5/1/2013 6:53:25 AM
|
|
|
4/30/2013 12:36:07 PM
|
Barclays Capital Is Lowering HeartWare International Inc. (HTWR) FY14 Estimate To -1.79 From -0.45
|
|
4/30/2013 12:35:44 PM
|
Barclays Capital Is Increasing HeartWare International Inc. (HTWR) FY13 Estimate To -3.28 From -3.81
|
|
4/30/2013 12:31:59 PM
|
Barclays Capital Reiterates HeartWare International Inc. (HTWR) At Overweight With $100 Up From $95 Price Target
|
|
4/30/2013 9:36:19 AM
|
|
|
4/29/2013 6:45:35 PM
|
|
|
4/29/2013 4:49:25 PM
|
HeartWare Int'l Posts Q1 Loss Per Share Of $0.87 Vs. Loss $1.33 Year Ago
|
|
4/29/2013 4:20:59 PM
|
|
|
4/29/2013 3:00:37 PM
|
|
|
3/18/2013 12:23:29 PM
|
HeartWare Int'l Completes Public Offering Of 1.73 Mln Common Shares At $86.45/share
|
|
3/12/2013 11:54:27 PM
|
|
|
3/12/2013 8:42:52 PM
|
HeartWare Prices Public Offering Of 1.5 Mln Shares Of Common Stock At $86.45/share
|
|
3/12/2013 10:16:09 AM
|
|
|
3/11/2013 4:27:30 PM
|
|